Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Arsenite-induced Radiosensitization of Glioma Cells Is Dependent on p53 Deficiency

YASUHARU NINOMIYA, TATSUHIKO IMAOKA, KAZUHIRO DAINO, SHIZUKO KAKINUMA and TETSUO NAKAJIMA
Anticancer Research June 2023, 43 (6) 2551-2559; DOI: https://doi.org/10.21873/anticanres.16422
YASUHARU NINOMIYA
1Department of Radiation Effects Research, National Institute of Radiological Sciences, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ninomiya.yasuharu{at}qst.go.jp
TATSUHIKO IMAOKA
1Department of Radiation Effects Research, National Institute of Radiological Sciences, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHIRO DAINO
1Department of Radiation Effects Research, National Institute of Radiological Sciences, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIZUKO KAKINUMA
1Department of Radiation Effects Research, National Institute of Radiological Sciences, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TETSUO NAKAJIMA
1Department of Radiation Effects Research, National Institute of Radiological Sciences, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, Chiba, Japan;
2Department of Radioecology and Fukushima Project, National Institute of Radiological Sciences, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Surviving fraction of p53-proficient (U87MG-neo) and p53-deficient (U87MG-E6) glioma cells. Cells were pretreated for 1 h with 1.25 μM arsenite and then exposed to various doses of X-rays and heavy ion beams. Cell survival was measured in a colony formation assay. Each data point represents the mean value (n≥3); bars, SD.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Relationship between arsenite-induced radiosensitization and the increase in the percentage of U87MG-E6 cells in the late S/G2/M phase at 36 h post-treatment with arsenite plus radiation. (A) Flow cytometry results showing the cell cycle distribution of U87MG-neo and U87MG-E6 cells irradiated with X-rays in the presence/absence of arsenite; cells were gated on the M1 (Sub-G1), M2 (G1/early S phase), M3 (late S/G2/M phase), and M4 (>4N: hyperploidy) regions. The arrow shows a change in the increase in the percentage of cells in the late S/G2/M phase. (B) Percentage of cells in the G1/early S phase and in the late S/G2/M phases, and the percentage of cells showing hyperploidy. Data are expressed as the mean±SD (n≥3). *p<0.05 (Student’s t-test).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Induction of γH2AX foci in U87MG-neo and U87MG-E6 cells at 24 h post-treatment with arsenite and/or irradiation. (A) Flow cytometry gating of γH2AX-positive cells was set at the cross-point of nonirradiated control (broken line) and the combination of arsenite plus irradiation (solid line). A typical result for U87MG-neo cells is shown. (B) Summary of flow cytometry analyses of the percentage of γH2AX-positive U87MG-neo and U87MG-E6 cells irradiated in the presence/absence of arsenite. The vertical axis shows the percentage of positive cells. (C) Summary of flow cytometry analyses of the percentage of γH2AX-positive U87MG-neo and U87MG-E6 cells irradiated in the presence/absence of arsenite. The vertical axis shows the percentage of positive cells, values after subtraction of the value of the nontreated control group. Data are expressed as the mean±SD (n≥3). *p<0.05, **p<0.01 (Student’s t-test).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Proposed model mechanism underlying radiosensitization of p53-deficient glioma cells by arsenite. In our previous study (15), we found that arsenite induced radiosensitization by generating reactive oxygen species (ROS), which inhibited BRCA2-mediated repair of DNA damage (broken lines). The present study (solid lines) shows that radiation increases DNA double strand breaks (DSB) and γH2AX foci (which are suppressed by p53) and increases the percentage of cells in the late S/G2/M phases (which is suppressed by p53). Therefore, deficiency of p53 increases radiosensitivity.

Tables

  • Figures
  • Table I.
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (6)
Anticancer Research
Vol. 43, Issue 6
June 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Arsenite-induced Radiosensitization of Glioma Cells Is Dependent on p53 Deficiency
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Arsenite-induced Radiosensitization of Glioma Cells Is Dependent on p53 Deficiency
YASUHARU NINOMIYA, TATSUHIKO IMAOKA, KAZUHIRO DAINO, SHIZUKO KAKINUMA, TETSUO NAKAJIMA
Anticancer Research Jun 2023, 43 (6) 2551-2559; DOI: 10.21873/anticanres.16422

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Arsenite-induced Radiosensitization of Glioma Cells Is Dependent on p53 Deficiency
YASUHARU NINOMIYA, TATSUHIKO IMAOKA, KAZUHIRO DAINO, SHIZUKO KAKINUMA, TETSUO NAKAJIMA
Anticancer Research Jun 2023, 43 (6) 2551-2559; DOI: 10.21873/anticanres.16422
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway
  • Coumarin-based Oximes Exert Monoamine Oxidase Inhibitory Activity
  • Selective Inhibition of Protein Kinase D2 Activity Reduces Human Neutrophil Survival
Show more Experimental Studies

Keywords

  • Glioma
  • arsenite
  • radiosensitization
  • heavy ion beam
  • P53
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire